Chris J. Bai

Biography

Chris J. Bai Ph.D, is president and CEO and globally responsible for the company including USA and China operations. Prior to AmbioPharm, Dr. Bai was president and CEO of American Peptide Company building the cGMP manufacturing business for American Peptide Company during his 5 years’ tenure. Prior to American Peptide Company, He was Senior Research and Development Scientist in the Peptide Section at Abbott Laboratories (N. Chicago, IL) where he was responsible for peptide process development, scale up and cGMP manufacturing.   He was involved in numerous peptide process development projects and cGMP manufacturing of peptides over a six-year period at Abbott, including the process development and manufacturing of a 22-amino acid peptide on a 40 kg scale by solution phase chemistry.

Research Interest

 peptide process development, cGMP manufacturing of peptides,scale up